{"product_id":"tonsillitis-mandelentzundung-peritonsillarabszess-und-sepsis-akute-entzundungen-und-mogliche-schwere-komplikationen-unterstutzung-homoopathie-nach-dr-banerji-kopie","title":"Immune thrombocytopenia (ITP, formerly idiopathic thrombocytopenic purpura) – platelet deficiency with increased bleeding tendency \"Support\" Homeopathy according to Dr. Banerji","description":"\u003ch2\u003eDr. Banerji Protocols\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eImmune thrombocytopenia (ITP, formerly idiopathic thrombocytopenic purpura) – deficiency of platelets with increased bleeding tendency\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eImmune thrombocytopenia (ITP)\u003c\/strong\u003e, formerly known as \u003cstrong\u003eidiopathic thrombocytopenic purpura\u003c\/strong\u003e, is an acquired disorder in which the number of \u003cstrong\u003eplatelets\u003c\/strong\u003e in the blood is reduced.\u003c\/p\u003e\n\u003cp\u003ePlatelets are essential for blood clotting. In severe thrombocytopenia, the tendency to bleed may therefore be increased.\u003c\/p\u003e\n\u003cp\u003eToday, the term \u003cstrong\u003eimmune thrombocytopenia\u003c\/strong\u003e is predominantly used, as it is known that immunological mechanisms play a central role in the disease.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhat happens in ITP?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIn ITP, the immune system targets the body's own platelets or structures involved in their formation.\u003c\/p\u003e\n\u003cp\u003eThis can lead to:\u003c\/p\u003e\n\u003cul\u003e\n\n\u003cli\u003e\n\n\u003cp\u003eaccelerated platelet destruction\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cp\u003ereduced platelet production in the bone marrow\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cp\u003eoverall significantly reduced platelet count\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\u003cp\u003e.\u003c\/p\u003e\n\u003cp\u003eBreakdown occurs, among other places, in the spleen and other areas of the mononuclear phagocyte system.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTypical symptoms\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe symptoms depend, among other things, on the platelet count and individual bleeding tendency.\u003c\/p\u003e\n\u003cp\u003ePossible symptoms include:\u003c\/p\u003e\n\u003cul\u003e\n\n\u003cli\u003e\n\n\u003cp\u003esmall pinpoint skin hemorrhages (\u003cstrong\u003epetechiae\u003c\/strong\u003e)\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cp\u003elarger skin hemorrhages (\u003cstrong\u003epurpura\u003c\/strong\u003e)\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cp\u003eunusually many bruises\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cp\u003enosebleeds\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cp\u003egum bleeding\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cp\u003eprolonged bleeding after minor injuries\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cp\u003eheavy menstrual bleeding\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cp\u003emucosal bleeding\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\u003cp\u003eSome people have only minor or no symptoms despite a significantly reduced platelet count.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePetechiae and Purpura\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePetechiae\u003c\/strong\u003e are small, pinpoint hemorrhages into the skin. They typically do not blanch when pressed.\u003c\/p\u003e\n\u003cp\u003eLarger, flat skin hemorrhages are called \u003cstrong\u003epurpura\u003c\/strong\u003e or ecchymoses.\u003c\/p\u003e\n\u003cp\u003eSuch changes can occur in ITP, but are not specific to this disease. Other clotting disorders, infections, medications, or hematological diseases can also cause similar skin changes.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eAcute and chronic ITP\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIn children, ITP often occurs after an infection and can spontaneously resolve within a few months.\u003c\/p\u003e\n\u003cp\u003eIn adults, a more prolonged or chronic course is more common.\u003c\/p\u003e\n\u003cp\u003eDepending on the duration, a distinction is made between newly diagnosed, persistent, and chronic ITP.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePrimary and secondary ITP\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIn \u003cstrong\u003eprimary ITP\u003c\/strong\u003e, there is no other clearly underlying disease.\u003c\/p\u003e\n\u003cp\u003eA \u003cstrong\u003esecondary immune thrombocytopenia\u003c\/strong\u003e can occur in conjunction with other diseases or factors, such as:\u003c\/p\u003e\n\u003cul\u003e\n\n\u003cli\u003e\n\n\u003cp\u003eautoimmune diseases such as systemic lupus erythematosus\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cp\u003ecertain viral infections\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cp\u003eHIV\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cp\u003eHepatitis C\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cp\u003ecertain lymphatic or hematological diseases\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cp\u003esome medications\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\u003cp\u003eTherefore, diagnostics also include the search for possible secondary causes.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eThrombocytopenia does not automatically mean ITP\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA reduced platelet count can have numerous other causes.\u003c\/p\u003e\n\u003cp\u003eThese include, among others:\u003c\/p\u003e\n\u003cul\u003e\n\n\u003cli\u003e\n\n\u003cp\u003emedications\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cp\u003esevere infections\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cp\u003eliver diseases\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cp\u003eenlarged spleen\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cp\u003ebone marrow diseases\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cp\u003evitamin deficiencies\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cp\u003ethrombotic thrombocytopenic purpura (TTP)\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cp\u003edisseminated intravascular coagulation (DIC)\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cp\u003epregnancy-associated thrombocytopenia\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\u003cp\u003eThese diseases may sometimes require completely different and urgent treatment.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDiagnosis\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe diagnosis of ITP is essentially a \u003cstrong\u003ediagnosis of exclusion\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003eInvestigations may include:\u003c\/p\u003e\n\u003cul\u003e\n\n\u003cli\u003e\n\n\u003cp\u003ecomplete blood count\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cp\u003erepeated platelet count determination\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cp\u003eexamination of the blood smear\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cp\u003ecoagulation parameters\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cp\u003eliver and kidney values\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cp\u003etesting for certain infections\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cp\u003eclarification of possible autoimmune diseases\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cp\u003ereview of medications taken\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\u003cp\u003eIn selected cases, further hematological examinations, including a bone marrow examination, may be necessary.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePseudothrombocytopenia\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIn the case of an unexpectedly low platelet count, so-called \u003cstrong\u003epseudothrombocytopenia\u003c\/strong\u003e should also be ruled out.\u003c\/p\u003e\n\u003cp\u003eIn this condition, platelets clump together in the blood sample, causing the laboratory device to falsely report a low platelet count.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTreatment\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNot every patient with ITP immediately requires drug therapy.\u003c\/p\u003e\n\u003cp\u003eThe decision depends not solely on a single platelet count, but particularly on:\u003c\/p\u003e\n\u003cul\u003e\n\n\u003cli\u003e\n\n\u003cp\u003ebleeding signs\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cp\u003eplatelet count level\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cp\u003eage\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cp\u003ecomorbidities\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cp\u003emedication intake\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cp\u003eindividual bleeding risks\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cp\u003eplanned surgeries or procedures\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\u003cp\u003eIn cases of low bleeding tendency, controlled observation may be sufficient in certain situations.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCorticosteroids and Immunoglobulins\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIf treatment is required, \u003cstrong\u003ecorticosteroids\u003c\/strong\u003e in particular may be used.\u003c\/p\u003e\n\u003cp\u003eIn cases of increased bleeding risk or when a rapid increase in platelets is necessary, \u003cstrong\u003eintravenous immunoglobulins (IVIG)\u003c\/strong\u003e may be used.\u003c\/p\u003e\n\u003cp\u003eThe effect can be rapid but is often temporary.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFurther treatment options\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFor persistent or chronic ITP, further therapies are available, such as:\u003c\/p\u003e\n\u003cul\u003e\n\n\u003cli\u003e\n\n\u003cp\u003ethrombopoietin receptor agonists\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cp\u003erituximab\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cp\u003efurther immunomodulatory or immunosuppressive therapies\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cp\u003esplenectomy in selected cases\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\u003cp\u003eThe choice depends on the individual course of the disease and the benefit-risk profile.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePlatelet transfusion\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003ePlatelet transfusion is not routinely performed in ITP solely due to a low platelet count.\u003c\/p\u003e\n\u003cp\u003eHowever, in cases of \u003cstrong\u003elife-threatening or severe acute bleeding\u003c\/strong\u003e, platelets may be necessary along with other specific measures.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedications and bleeding risk\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIn severe thrombocytopenia, medications that affect platelet function or blood clotting can further increase the risk of bleeding.\u003c\/p\u003e\n\u003cp\u003eThese include, for example:\u003c\/p\u003e\n\u003cul\u003e\n\n\u003cli\u003e\n\n\u003cp\u003eacetylsalicylic acid (ASA)\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cp\u003ecertain non-steroidal anti-inflammatory drugs\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cp\u003eanticoagulants\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\u003cp\u003eWhether such medications should be discontinued, avoided, or continued must be decided individually by a medical professional. Prescribed anticoagulants should not be stopped independently.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRisk of severe bleeding\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eMost ITP patients do not develop life-threatening bleeding. However, the risk increases with very severe thrombocytopenia.\u003c\/p\u003e\n\u003cp\u003eParticularly feared are:\u003c\/p\u003e\n\u003cul\u003e\n\n\u003cli\u003e\n\n\u003cp\u003esevere gastrointestinal bleeding\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cp\u003epronounced mucosal bleeding\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli\u003e\n\n\u003cp\u003eintracranial hemorrhages\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\u003cp\u003eCerebral hemorrhage is rare but represents a life-threatening complication.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eITP in pregnancy\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eImmune thrombocytopenia can also exist during pregnancy or be diagnosed for the first time.\u003c\/p\u003e\n\u003cp\u003eIt must be differentiated from other causes of thrombocytopenia in pregnancy.\u003c\/p\u003e\n\u003cp\u003eManagement is carried out in close cooperation between obstetrics and hematology, depending on the severity.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHomeopathy according to Dr. Banerji\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIn homeopathy according to \u003cstrong\u003eDr. Banerji\u003c\/strong\u003e, for bleeding tendency, purpura, and various hematological complaints, specific homeopathic remedies and potencies are used according to the Banerji protocols.\u003c\/p\u003e\n\u003cp\u003eA reliable \u003cstrong\u003enormalization of the platelet count, treatment of the underlying immune thrombocytopenia, or prevention of severe bleeding through homeopathic remedies is not scientifically proven\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003eNecessary hematological monitoring and treatment with corticosteroids, immunoglobulins, or other specific therapies must not be replaced or delayed by homeopathic remedies.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eImportant note\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIn cases of \u003cstrong\u003esevere or uncontrollable bleeding, blood in vomit or stool, pronounced mucosal bleeding, sudden very severe headaches, visual disturbances, speech disorders, paralysis, altered consciousness, or after a relevant head injury with severe thrombocytopenia\u003c\/strong\u003e, immediate medical evaluation is required.\u003c\/p\u003e\n\u003cp\u003eA newly detected significant thrombocytopenia should always be medically or hematologically clarified, as other treatable causes besides ITP may be present.\u003c\/p\u003e\n\u003cp\u003eThe information on this page is for general information purposes only and does not replace medical advice, diagnosis, or treatment.\u003c\/p\u003e\n\u003cp\u003eIngredients: Hamamelis virg., Arnica montana, Kalium mur., Ferrum phosph., Crotalus horridus, Medorrhinum\u003c\/p\u003e","brand":"Heiligen Geist Apotheke","offers":[{"title":"1 fl oz","offer_id":60607129256270,"sku":null,"price":35.9,"currency_code":"EUR","in_stock":true},{"title":"50ml","offer_id":60607129289038,"sku":null,"price":49.9,"currency_code":"EUR","in_stock":true},{"title":"100ml","offer_id":60607129321806,"sku":null,"price":75.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0684\/0451\/0998\/files\/DIL_NEW.jpg?v=1760452935","url":"https:\/\/aqveo.at\/en\/products\/tonsillitis-mandelentzundung-peritonsillarabszess-und-sepsis-akute-entzundungen-und-mogliche-schwere-komplikationen-unterstutzung-homoopathie-nach-dr-banerji-kopie","provider":"Heiligen Geist Apotheke ","version":"1.0","type":"link"}